Subscribe to RSS
DOI: 10.1055/a-0880-6182
Influence of Foetal Macrosomia on the Neonatal and Maternal Birth Outcome
Article in several languages: English | deutschPublication History
received 29 November 2018
revised 18 February 2019
accepted 20 March 2019
Publication Date:
11 November 2019 (online)
Abstract
Introduction Foetal macrosomia is associated with various obstetrical complications and is a common reason for inductions and primary or secondary Caesarean sections. The objective of this study is the generation of descriptive data on the mode of delivery and on maternal and foetal complications in the case of foetal macrosomia. The causes and consequences of foetal macrosomia as well as the rate of shoulder dystocia are examined in relation to the severity of the macrosomia.
Patients The study investigated all singleton births ≥ 37 + 0 weeks of pregnancy with a birth weight ≥ 4000 g at the Charité University Medicine Berlin (Campus Mitte 2001 – 2017, Campus Virchow Klinikum 2014 – 2017).
Results 2277 consecutive newborns (birth weight 4000 – 4499 g [88%], 4500 – 4999 g [11%], ≥ 5000 g [1%]) were included. Maternal obesity and gestational diabetes were more common in the case of newborns weighing ≥ 4500 g than newborns weighing 4000 – 4499 g (p = 0.001 and p < 0.001). Women with newborns ≥ 5000 g were more often ≥ 40 years of age (p = 0.020) and multipara (p = 0.025). The mode of delivery was spontaneous in 60% of cases, vaginal-surgical in 9%, per primary section in 14% and per secondary section in 17%. With a birth weight ≥ 4500 g, a vaginal delivery was more rare (p < 0.001) and the rate of secondary sections was increased (p = 0.011). Women with newborns ≥ 4500 g suffered increased blood loss more frequently (p = 0.029). There was no significant difference with regard to the rate of episiotomies or serious birth injuries. Shoulder dystocia occurred more frequently at a birth weight of ≥ 4500 g (5 vs. 0.9%, p = 0.000). Perinatal acidosis occurred in 2% of newborns without significant differences between the groups. Newborns ≥ 4500 g were transferred to neonatology more frequently (p < 0.001).
Conclusion An increased birth weight is associated with an increased maternal risk and an increased rate of primary and secondary sections as well as shoulder dystocia; no differences in the perinatal outcome between newborns with a birth weight of 4000 – 4499 g and ≥ 4500 g were seen. In our collective, a comparably low incidence of shoulder dystocia was seen. In the literature, the frequency is indicated with a large range (1.9 – 10% at 4000 – 4499 g, 2.5 – 20% at 4500 – 5000 g and 10 – 20% at ≥ 5000 g). One possible cause for the low rate could be the equally low prevalence of gestational diabetes in our collective. A risk stratification of the pregnant women (e.g. avoidance of vacuum extraction, taking gestational diabetes into account during delivery planning) is crucial. If macrosomia is presumed, it is recommended that delivery take place at a perinatal centre in the presence of a specialist physician, due to the increased incidence of foetal and maternal complications.
-
References/Literatur
- 1 American College of Obstetricians and Gynecologistsʼ Committee on Practice Bulletins—Obstetrics. Practice Bulletin No. 173: Fetal Macrosomia. Obstet Gynecol 2016; 128: e195-e209
- 2 Zhang X, Decker A, Platt RW. et al. How big is too big? The perinatal consequences of fetal macrosomia. Am J Obstet Gynecol 2008; 198: 517.e1-517.e6
- 3 Boulet SL, Alexander GR, Salihu HM. et al. Macrosomic births in the united states: determinants, outcomes, and proposed grades of risk. Am J Obstet Gynecol 2003; 188: 1372-1378
- 4 Tian C, Hu C, He X. et al. Excessive weight gain during pregnancy and risk of macrosomia: a meta-analysis. Arch Gynecol Obstet 2016; 293: 29-35
- 5 Lanowski JS, Lanowski G, Schippert C. et al. Ultrasound versus Clinical Examination to Estimate Fetal Weight at Term. Geburtsh Frauenheilk 2017; 77: 276-283
- 6 Institut für Qualitätssicherung und Transparenz im Gesundheitswesen. Bundesauswertung zum Erfassungsjahr 2016. 12.07.2017 Online: https://iqtig.org/downloads/auswertung/2016/16n1gebh/QSKH_16n1-GEBH_2016_BUAW_V02_2017-07-12.pdf last access: 18.01.2019
- 7 Voigt M, Wittwer-Backofen U, Scholz R. et al. Analysis of the German perinatal survey of the years 2007–2011 and comparison with data from 1995–1997: neonatal characteristics and duration of pregnancy. Z Geburtshilfe Neonatol 2013; 217: 211-214
- 8 Stotland NE, Caughey AB, Breed EM. et al. Risk factors and obstetric complications associated with macrosomia. Int J Gynaecol Obstet 2004; 87: 220-226
- 9 Ehrenberg HM, Mercer BM, Catalano PM. The influence of obesity and diabetes on the prevalence of macrosomia. Am J Obstet Gynecol 2004; 191: 964-968
- 10 Gross SJ, Shime J, Farine D. Shoulder dystocia: predictors and outcome. A five-year review. Am J Obstet Gynecol 1987; 156: 334-336
- 11 Herzberg S, Kabiri D, Mordechai T. et al. Fetal macrosomia as a risk factor for shoulder dystocia during vacuum extraction. J Matern Fetal Neonatal Med 2017; 30: 1870-1873
- 12 Oral E, Cagdas A, Gezer A. et al. Perinatal and maternal outcomes of fetal macrosomia. Eur J Obstet Gynecol Reprod Biol 2001; 99: 167-171
- 13 Chauhan SP, Grobman WA, Gherman RA. et al. Suspicion and treatment of the macrosomic fetus: a review. Am J Obstet Gynecol 2005; 193: 332-346
- 14 Peliowski-Davidovich A. Canadian Paediatric Society, Fetus and Newborn Committee. Hypothermia for newborns with hypoxic ischemic encephalopathy. Paediatr Child Health 2012; 17: 41-46
- 15 Fuchs F, Bouyer J, Rozenberg P. et al. Adverse maternal outcomes associated with fetal macrosomia: what are the risk factors beyond birthweight?. BMC Pregnancy Childbirth 2013; 13: 90
- 16 Nesbitt TS, Gilbert WM, Herrchen B. Shoulder dystocia and associated risk factors with macrosomic infants born in California. Am J Obstet Gynecol 1998; 179: 476-480
- 17 Hill MG, Cohen WR. Shoulder dystocia: prediction and management. Womens Health (Lond) 2016; 12: 251-261
- 18 Turkmen S, Johansson S, Dahmoun M. Foetal Macrosomia and Foetal-Maternal Outcomes at Birth. J Pregnancy 2018; 2018: 4790136
- 19 Alsunnari S, Berger H, Sermer M. et al. Obstetric outcome of extreme macrosomia. J Obstet Gynaecol Can 2005; 27: 323-328
- 20 Kehila M, Derouich S, Touhami O. et al. Macrosomia, shoulder dystocia and elongation of the brachial plexus: what is the role of caesarean section?. Pan Afr Med J 2016; 25: 217
- 21 Deutsche Gesellschaft für Gynäkologie und Geburtshilfe, Arbeitsgemeinschaft Medizinrecht. S1-Leitlinie: Empfehlungen zur Schulterdystokie. Erkennung, Prävention und Management. AWMF 015/024. 2010 (2013 abgelaufen). Online: https://www.dggg.de/fileadmin/documents/leitlinien/archiviert/federfuehrend/015024_Empfehlungen_zur_Schulterdystokie/015024_2010.pdf last access: 17.02.2019
- 22 Langer O, Rodriguez DA, Xenakis EM. et al. Intensified versus conventional management of gestational diabetes. Am J Obstet Gynecol 1994; 170: 1036-1046 discussion 1046-1037
- 23 World Health Organization. WHO recommendations for the prevention and treatment of postpartum haemorrhage. Geneva: WHO; 2012 Online: https://apps.who.int/iris/bitstream/handle/10665/75411/9789241548502_eng.pdf?sequence=1 last access: 12.05.2019
- 24 Boulvain M, Irion O, Dowswell T. et al. Induction of labour at or near term for suspected fetal macrosomia. Cochrane Database Syst Rev 2016; (05) CD000938 doi:10.1002/14651858.CD000938.pub2
- 25 Grobman WA, Rice MM, Reddy UM. et al. Labor Induction versus Expectant Management in Low-Risk Nulliparous Women. N Engl J Med 2018; 379: 513-523
- 26 Deutsche Gesellschaft für Gynäkologie und Geburtshilfe, Deutsche Diabetes Gesellschaft. S3-Leitlinie Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge, 2. Auflage (2018). Online: https://www.deutsche-diabetes-gesellschaft.de/fileadmin/Redakteur/Leitlinien/Evidenzbasierte_Leitlinien/2018/057-008l_S3_Gestationsdiabetes-mellitus-GDM-Diagnostik-Therapie-Nachsorge_2018-03.pdf last access: 18.02.2019
- 27 Schafer-Graf UM. Gestational Diabetes – Major New Clinically Relevant Aspects. Geburtsh Frauenheilk 2018; 78: 977-983
- 28 Schäfer-Graf UM, Gembruch U, Kainer F. et al. Gestational Diabetes Mellitus (GDM) – Diagnosis, Treatment and Follow-Up. Guideline of the DDG and DGGG (S3 Level, AWMF Registry Number 057/008, February 2018). Geburtsh Frauenheilk 2018; 78: 1219-1231